抗炎症治療薬の世界市場レポート 2025年

抗炎症治療薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.0%で、1,440億5,000万米ドルに成長します。予測期間の成長は、革新的な治療法、ヘルスケア支出の増加、希少疾患への注力、生物製剤、バイオシミラーに起因すると考えられます。予測期間の主な動向には、免疫療法の進歩、創薬における人工知能（AI）と機械学習（ML）、適応症の拡大などがあります。

炎症性腸疾患の罹患率の増加は、抗炎症治療薬市場の拡大を牽引するとみられます。炎症性腸疾患（IBD）は、消化管の炎症を特徴とする慢性疾患です。抗炎症治療薬は炎症を抑え、症状を管理し、手術の可能性を低くするため、クローン病などの治療において極めて重要な役割を果たしています。例えば、オックスフォード大学の大学出版局であるオックスフォード大学出版局（OUP）が2023年7月に発表したレポートによると、IBDの発症率は10万人年あたり10.9人、有病率は10万人あたり721人です。その結果、炎症性腸疾患の有病率の上昇は、抗炎症治療薬市場の成長を促す重要な要因となっています。

自己免疫疾患の有病率の増加は、今後の抗炎症治療薬市場の拡大を牽引すると予想されます。自己免疫疾患は、細菌やウイルスのような有害な侵入者を防御する一般的な役割を担う身体の免疫システムが、誤って身体自身の健康な細胞や組織を標的にし、攻撃してしまう病状群を包含しています。自己免疫疾患の有病率の増加は、抗炎症治療薬の需要増加に重要な役割を果たしています。これらの治療薬は自己免疫疾患の治療に頻繁に使用され、炎症を抑え、過剰な免疫反応を調整し、これらの症状に関連する症状を緩和することを目的としています。例えば、英国のメディア企業Guardian Media Groupが2022年1月に報じたように、英国では自己免疫疾患に苦しむ人が400万人いると推定されており、世界の増加率は毎年3％から9％と推定されています。さらに、英国の研究大学であるオックスフォード大学が2023年5月に発表したデータによると、自己免疫疾患は世界人口の10％に影響を及ぼします。その結果、自己免疫疾患の有病率の上昇が抗炎症治療薬市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の抗炎症治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の抗炎症治療薬市場：成長率分析
• 世界の抗炎症治療薬市場の実績：規模と成長, 2019-2024
• 世界の抗炎症治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の抗炎症治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗炎症治療薬市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬（NSAID）
• コルチコステロイド
• 抗炎症生物学的製剤
• 世界の抗炎症治療薬市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 関節炎
• 呼吸器疾患
• 多発性硬化症
• 乾癬
• 炎症性腸疾患
• その他の炎症性疾患
• 世界の抗炎症治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売薬局
• 病院薬局
• オンライン流通
• 世界の抗炎症治療薬市場、タイプ別サブセグメンテーション：非ステロイド性抗炎症薬（NSAID）、実績と予測, 2019-2024, 2024-2029F, 2034F
• イブプロフェン
• アスピリン
• ナプロキセン
• ジクロフェナク
• セレコキシブ
• インドメタシン
• ケトプロフェン
• 世界の抗炎症治療薬市場、タイプ別サブセグメンテーション：コルチコステロイド、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレドニゾン
• デキサメタゾン
• ヒドロコルチゾン
• メチルプレドニゾロン
• トリアムシノロン
• ベタメタゾン
• 世界の抗炎症治療薬市場、タイプ別サブセグメンテーション：抗炎症生物学的製剤、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍壊死因子（TNF）阻害剤
• インターロイキン阻害剤
• ヤヌスキナーゼ（JAK）阻害剤
• モノクローナル抗体
• 組み換えタンパク質
• 融合タンパク質

第7章 地域別・国別分析

• 世界の抗炎症治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗炎症治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗炎症治療薬市場：競合情勢
• 抗炎症治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Novartis AG
• Sanofi-Aventis LLC.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GlaxoSmithKline plc.
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Co Ltd.
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Biogen Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗炎症治療薬市場2029：新たな機会を提供する国
• 抗炎症治療薬市場2029：新たな機会を提供するセグメント
• 抗炎症治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anti-inflammatory therapeutics are prescription drugs designed to address pain, reduce inflammation, and lower elevated body temperatures. They function as modifiers of the body's immune response and are essential in the management of both acute and chronic conditions such as headaches, painful episodes, as well as sprains and strains.

The primary categories of drug classes used in anti-inflammatory therapeutics encompass nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and anti-inflammatory biologics. Nonsteroidal anti-inflammatory drugs are analgesic medications without opioids that are commonly employed by individuals to alleviate mild physical discomfort. These medications find diverse applications in conditions like arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel diseases, and more. They are available through a range of distribution channels, including retail pharmacies, hospital pharmacies, and online retail platforms.

The anti-inflammatory therapeutics market research report is one of a series of new reports from The Business Research Company that provides anti-inflammatory therapeutics market statistics, including anti-inflammatory therapeutics industry global market size, regional shares, competitors with an anti-inflammatory therapeutics market share, detailed anti-inflammatory therapeutics market segments, market trends and opportunities and any further data you may need to thrive in the anti-inflammatory therapeutics industry. These anti-inflammatory therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $114.71 billion in 2024 to $118.44 billion in 2025 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives.

The anti-inflammatory therapeutics market size is expected to see strong growth in the next few years. It will grow to $144.05 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications.

The growing incidence of inflammatory bowel disease is set to drive the expansion of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a chronic condition characterized by inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics play a pivotal role in the treatment of conditions like Crohn's disease, as they help reduce inflammation, manage symptoms, and lower the likelihood of surgery. For example, a July 2023 report from Oxford University Press (OUP), the university press of the University of Oxford, indicates that IBD has an incidence of 10.9 per 100,000 person-years and a prevalence of 721 per 100,000 people. Consequently, the rising prevalence of inflammatory bowel disease is a significant driver of growth in the anti-inflammatory therapeutics market.

The increasing prevalence of autoimmune disorders is expected to drive the expansion of the anti-inflammatory therapeutics market in the future. Autoimmune disorders encompass a group of medical conditions where the body's immune system, typically responsible for defending against harmful invaders like bacteria and viruses, erroneously targets and attacks the body's own healthy cells and tissues. The growing prevalence of autoimmune disorders plays a significant role in the increasing demand for anti-inflammatory therapeutics. These therapeutics are frequently employed in the treatment of autoimmune disorders, aiming to reduce inflammation, regulate the overactive immune response, and alleviate the symptoms associated with these conditions. For instance, as reported in January 2022 by the Guardian Media Group, a UK-based media company, it is anticipated that there will be 4 million people in the UK suffering from autoimmune disorders, with a global increase estimated at 3% to 9% annually. Additionally, data from May 2023 from the University of Oxford, a UK-based research university, indicates that autoimmune disorders affect 10% of the world's population. Consequently, the rising prevalence of autoimmune disorders is a driving force behind the growth of the anti-inflammatory therapeutics market.

Prominent companies within the anti-inflammatory therapeutics market are actively introducing innovative drugs as a strategy to enhance their market presence. As an example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, jointly introduced Kevzara (sarilumab). This represents the first and only anti-inflammatory biologic designed for adult patients dealing with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition. It is particularly targeted at individuals who either do not respond adequately to corticosteroids or cannot tolerate corticosteroid tapering.

In March 2022, Pfizer Inc., a US-based biopharmaceutical company, completed a $6.7 billion acquisition of Arena Pharmaceuticals. This strategic move by Pfizer is intended to enhance its portfolio in the field of inflammation and immunology therapeutics, with a focus on conditions such as ulcerative colitis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. Arena Pharmaceuticals, a US-based company, specializes in the development of diverse anti-inflammatory drugs for the treatment of various immuno-inflammatory disorders.

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anti-inflammatory therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-inflammatory therapeutics market consists of sales of Ibuprofen, naproxen, and diclofenac. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Inflammatory Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-inflammatory therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-inflammatory therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-inflammatory therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Corticosteroids; Anti-Inflammatory Biologics
• 2) By Indication: Arthritis; Respiratory Diseases; Multiple Sclerosis; Psoriasis; Inflammatory Bowel Diseases; Other Inflammatory Diseases
• 3) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Distribution
• Subsegments:
• 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Aspirin; Naproxen; Diclofenac; Celecoxib; Indomethacin; Ketoprofen
• 2) By Corticosteroids: Prednisone; Dexamethasone; Hydrocortisone; Methylprednisolone; Triamcinolone; Betamethasone
• 3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors; Janus Kinase (JAK) Inhibitors; Monoclonal Antibodies; Recombinant Proteins; Fusion Proteins
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; F. Hoffmann-La Roche Ltd.; Merck and Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anti-Inflammatory Therapeutics Market Characteristics

3. Anti-Inflammatory Therapeutics Market Trends And Strategies

4. Anti-Inflammatory Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Anti-Inflammatory Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anti-Inflammatory Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anti-Inflammatory Therapeutics Market Growth Rate Analysis
• 5.4. Global Anti-Inflammatory Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anti-Inflammatory Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anti-Inflammatory Therapeutics Total Addressable Market (TAM)

6. Anti-Inflammatory Therapeutics Market Segmentation

• 6.1. Global Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroids
• Anti-Inflammatory Biologics
• 6.2. Global Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arthritis
• Respiratory Diseases
• Multiple Sclerosis
• Psoriasis
• Inflammatory Bowel Diseases
• Other Inflammatory Diseases
• 6.3. Global Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• Online Distribution
• 6.4. Global Anti-Inflammatory Therapeutics Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ibuprofen
• Aspirin
• Naproxen
• Diclofenac
• Celecoxib
• Indomethacin
• Ketoprofen
• 6.5. Global Anti-Inflammatory Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prednisone
• Dexamethasone
• Hydrocortisone
• Methylprednisolone
• Triamcinolone
• Betamethasone
• 6.6. Global Anti-Inflammatory Therapeutics Market, Sub-Segmentation Of Anti-Inflammatory Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Necrosis Factor (TNF) Inhibitors
• Interleukin Inhibitors
• Janus Kinase (JAK) Inhibitors
• Monoclonal Antibodies
• Recombinant Proteins
• Fusion Proteins

7. Anti-Inflammatory Therapeutics Market Regional And Country Analysis

• 7.1. Global Anti-Inflammatory Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anti-Inflammatory Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Inflammatory Therapeutics Market

• 8.1. Asia-Pacific Anti-Inflammatory Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Inflammatory Therapeutics Market

• 9.1. China Anti-Inflammatory Therapeutics Market Overview
• 9.2. China Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Inflammatory Therapeutics Market

• 10.1. India Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Inflammatory Therapeutics Market

• 11.1. Japan Anti-Inflammatory Therapeutics Market Overview
• 11.2. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Inflammatory Therapeutics Market

• 12.1. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Inflammatory Therapeutics Market

• 13.1. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Inflammatory Therapeutics Market

• 14.1. South Korea Anti-Inflammatory Therapeutics Market Overview
• 14.2. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Inflammatory Therapeutics Market

• 15.1. Western Europe Anti-Inflammatory Therapeutics Market Overview
• 15.2. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Inflammatory Therapeutics Market

• 16.1. UK Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Inflammatory Therapeutics Market

• 17.1. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Inflammatory Therapeutics Market

• 18.1. France Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Inflammatory Therapeutics Market

• 19.1. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Inflammatory Therapeutics Market

• 20.1. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Inflammatory Therapeutics Market

• 21.1. Eastern Europe Anti-Inflammatory Therapeutics Market Overview
• 21.2. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Inflammatory Therapeutics Market

• 22.1. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Inflammatory Therapeutics Market

• 23.1. North America Anti-Inflammatory Therapeutics Market Overview
• 23.2. North America Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Inflammatory Therapeutics Market

• 24.1. USA Anti-Inflammatory Therapeutics Market Overview
• 24.2. USA Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Inflammatory Therapeutics Market

• 25.1. Canada Anti-Inflammatory Therapeutics Market Overview
• 25.2. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Inflammatory Therapeutics Market

• 26.1. South America Anti-Inflammatory Therapeutics Market Overview
• 26.2. South America Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Inflammatory Therapeutics Market

• 27.1. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Inflammatory Therapeutics Market

• 28.1. Middle East Anti-Inflammatory Therapeutics Market Overview
• 28.2. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Inflammatory Therapeutics Market

• 29.1. Africa Anti-Inflammatory Therapeutics Market Overview
• 29.2. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anti-Inflammatory Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Inflammatory Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Anti-Inflammatory Therapeutics Market Competitive Landscape
• 30.2. Anti-Inflammatory Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Inflammatory Therapeutics Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Sanofi-Aventis LLC.
• 31.4. Bristol-Myers Squibb Company
• 31.5. AstraZeneca PLC
• 31.6. GlaxoSmithKline plc.
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Co Ltd.
• 31.9. Amgen Inc.
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Viatris Inc.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Regeneron Pharmaceuticals Inc.
• 31.14. Astellas Pharma Inc.
• 31.15. Biogen Inc.

32. Global Anti-Inflammatory Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Inflammatory Therapeutics Market

34. Recent Developments In The Anti-Inflammatory Therapeutics Market

35. Anti-Inflammatory Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Anti-Inflammatory Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anti-Inflammatory Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anti-Inflammatory Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer